Safety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda

Direct‐acting antivirals for hepatitis C virus (HCV) are highly effective and well‐tolerated. However, only a small percentage of HCV‐infected individuals globally have received therapy. Reducing the complexity of monitoring during HCV therapy, if shown to be safe, could facilitate greater access to...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Hepatol Commun
Κύριοι συγγραφείς: Grant, Philip, Shumbusho, Fabienne, Van Nuil, Jennifer Ilo, Kateera, Fredrick, Mukherjee, Joia, Kabahizi, Jules, Ntaganda, Fabien, Nsanzimana, Sabin, Mbituyumuremyi, Aimable, Damascene, Makuza Jean, Muvunyi, Claude Mambo, Mukabatsinda, Constance, Musabeyezu, Emmanuel, Ntirenganya, Cyprien, Gupta, Neil
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2020
Θέματα:
Original Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7109339/
https://ncbi.nlm.nih.gov/pubmed/32258951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1482
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια